#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pseudoxanthoma elasticum Metachromatic leukodystrophy Superficial vein thrombosis Hepatoblastoma Vascular calcification Systemic lupus erythematosus Hereditary ataxia Chronic graft versus host disease in intestine Myotonic dystrophy Hereditary spastic paraplegia Anti-myelin-associated glycoprotein associated polyneuropathy Proteus syndrome Leukocyte adhesion deficiency type I Thrombotic thrombocytopenic purpura Immune-mediated enterocolitis More trials…

    Learn about Rare Diseases

    Nodal marginal zone B-cell lymphoma – Treatment Lymphangioma – Trials in Disease Acute respiratory distress syndrome – Trials in Disease Choroid melanoma – Trials in Disease Hepatoblastoma – Basic Information Waldenstrom’s macroglobulinaemia refractory – Basic Information Metachromatic leukodystrophy – Basic Information Pelizaeus-Merzbacher disease – Trials in Disease Testicular leiomyosarcoma Mucopolysaccharidosis II More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ripasudil Lysine Aspirin [14C]ZIPALERTINIB Protamine Sulfate Tebentafusp Sasanlimab Neomycin Sulfate Tofogliflozin Selpercatinib Telitacicept Eltrombopag Midodrine Hydrochloride Peginterferon Alfa-2A Ebastine Tpst-1120 Cx-044933 Tulmimetostat Ioflupane (123I) ZOLPIDEM TARTRATE GSK4524101A More therapies…

    Learn about Your Condition

    Urea cycle disorder Open angle glaucoma Cholangiocarcinoma Labour pain Drug dependence Iron overload Vulvar dysplasia Rectal neoplasm Fatty acid oxidation disorder Thalassaemia beta Cortical dysplasia Dry eye Mitral valve disease Piriformis syndrome Agitation postoperative More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Koranyi National Institute For Pulmonology

Koranyi National Institute For Pulmonology

Koranyi Frigyes Ut 1, Budapest, 1121, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

    Recruiting

    3 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Bi 1291583
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Recruiting

    3 1 1
    Investigated Drugs:
    • Palonosetron
    • Adagrasib
    • Carboplatin
    Austria Belgium Bulgaria Croatia France Germany +9

  • Study on Tozorakimab for Adults with Uncontrolled Asthma Using Medium-to-High Dose Inhaled Corticosteroids

    Recruiting

    2 1 1
    Investigated Drugs:
    • Tozorakimab
    • Salbutamol Sulfate
    France Greece Hungary Italy Spain

  • Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

    Recruiting

    3 1
    Investigated Diseases:
    • Acute respiratory failure
    Investigated Drugs:
    • Tozorakimab
    Belgium Bulgaria Czechia Denmark France Germany +8

  • Study comparing Rilvegostomig plus chemotherapy versus Pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Infliximab
    Belgium France Germany Hungary Italy The Netherlands +2

  • Study of IPH5201 and Durvalumab for Pre- and Post-Surgery Treatment in Patients with Early-Stage Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage II
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Iph5201
    • Carboplatin
    • Cisplatin
    France Greece Hungary Poland

  • Study on APL-101 for Treating Advanced Solid Tumors and Non-Small Cell Lung Cancer with MET Changes in Patients

    Recruiting

    1 1 1
    Investigated Diseases:
    • Central nervous system neoplasm
    • Neoplasm
    • Non-small cell lung cancer
    Investigated Drugs:
    • Apl-101
    France Hungary Italy Spain

  • Study on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    • Topotecan
    Austria Belgium Czechia France Germany Greece +7

  • Study Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer stage IV
    • Squamous cell carcinoma of lung
    Investigated Drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    • Mps-103
    Belgium France Germany Greece Hungary Italy +5

  • Study of Pembrolizumab, Vibostolimab, and Chemotherapy for Patients with Newly Diagnosed Resectable Stage II-IIIB Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Carboplatin
    • Cisplatin
    Germany Greece Hungary Italy Poland Spain
Previous Page
1 2 3 4 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!